The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
HONG KONG,Feb. 13,2025-- Regal Hotels International is leveraging its extensive hotel network to launch the exclusive "Long-stay Accommodation Programme" for Hospital Authority (HA) staff.
Business leaders feel their organizations\' resilience and ability to navigate a dynamically shifting risk landscape has been battle tested
Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets,Strengthening Collaboration with Distribution Partner McKesson
BERLIN,Feb. 11,2025-- Global corruption remains alarmingly high,according to the2024 Corruption Perceptions Index (CPI) released today by Transparency International. The report reveals that more than
Solidion files multiple patent applications on a new process to produce graphene ball-hosted silicon anode materials
